Panbela Therapeutics, Inc. Quarterly Return On Equity in % from Q3 2013 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Panbela Therapeutics, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2013 to Q3 2024.
  • Panbela Therapeutics, Inc. Return On Equity for the quarter ending September 30, 2024 was 305 %, a 89.6% decline year-over-year.
  • Panbela Therapeutics, Inc. annual Return On Equity for 2023 was -73.8K %, a 7798% decline from 2022.
  • Panbela Therapeutics, Inc. annual Return On Equity for 2022 was 958 %.
  • Panbela Therapeutics, Inc. annual Return On Equity for 2021 was -109 %, a 16.3% decline from 2020.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 305 -2.63K -89.6% Jul 1, 2024 Sep 30, 2024
Q2 2024 545 -348 -39% Apr 1, 2024 Jun 30, 2024
Q1 2024 1.95K +1.17K +150% Jan 1, 2024 Mar 31, 2024
Q4 2023 -73.8K -74.7K -7798% Oct 1, 2023 Dec 31, 2023
Q3 2023 2.94K +6.61K Jul 1, 2023 Sep 30, 2023
Q2 2023 893 +1.39K Apr 1, 2023 Jun 30, 2023
Q1 2023 781 +909 Jan 1, 2023 Mar 31, 2023
Q4 2022 958 +1.07K Oct 1, 2022 Dec 31, 2022
Q3 2022 -3.67K -3.58K -4239% Jul 1, 2022 Sep 30, 2022
Q2 2022 -495 -406 -456% Apr 1, 2022 Jun 30, 2022
Q1 2022 -128 -50.8 -66.1% Jan 1, 2022 Mar 31, 2022
Q4 2021 -109 -15.3 -16.3% Oct 1, 2021 Dec 31, 2021
Q3 2021 -84.5 +62.2 +42.4% Jul 1, 2021 Sep 30, 2021
Q2 2021 -89.1 +210 +70.3% Apr 1, 2021 Jun 30, 2021
Q1 2021 -76.9 +509 +86.9% Jan 1, 2021 Mar 31, 2021
Q4 2020 -93.9 +714 +88.4% Oct 1, 2020 Dec 31, 2020
Q3 2020 -147 +1.08K +88% Jul 1, 2020 Sep 30, 2020
Q2 2020 -299 -2.55K -113% Apr 1, 2020 Jun 30, 2020
Q1 2020 -586 -3.64K -119% Jan 1, 2020 Mar 31, 2020
Q4 2019 -808 -1.76K -185% Oct 1, 2019 Dec 31, 2019
Q3 2019 -1.22K -1.68K -368% Jul 1, 2019 Sep 30, 2019
Q2 2019 2.25K +1.87K +491% Apr 1, 2019 Jun 30, 2019
Q1 2019 3.05K +2.76K +954% Jan 1, 2019 Mar 31, 2019
Q4 2018 951 +303 +46.8% Oct 1, 2018 Dec 31, 2018
Q3 2018 455 -112 -19.7% Jul 1, 2018 Sep 30, 2018
Q2 2018 381 -88.5 -18.8% Apr 1, 2018 Jun 30, 2018
Q1 2018 289 -88.3 -23.4% Jan 1, 2018 Mar 31, 2018
Q4 2017 648 +505 +353% Oct 1, 2017 Dec 31, 2017
Q3 2017 567 +450 +385% Jul 1, 2017 Sep 30, 2017
Q2 2017 470 +347 +282% Apr 1, 2017 Jun 30, 2017
Q1 2017 378 +211 +127% Jan 1, 2017 Mar 31, 2017
Q4 2016 143 -227 -61.3% Oct 1, 2016 Dec 31, 2016
Q3 2016 117 -530 -81.9% Jul 1, 2016 Sep 30, 2016
Q2 2016 123 -1.03K -89.3% Apr 1, 2016 Jun 30, 2016
Q1 2016 167 -822 -83.1% Jan 1, 2016 Mar 31, 2016
Q4 2015 370 -266 -41.9% Oct 1, 2015 Dec 31, 2015
Q3 2015 647 +1.72K Jul 1, 2015 Sep 30, 2015
Q2 2015 1.15K +1.3K Apr 1, 2015 Jun 30, 2015
Q1 2015 988 +1.1K Jan 1, 2015 Mar 31, 2015
Q4 2014 636 +712 Oct 1, 2014 Dec 31, 2014
Q3 2014 -1.08K -1.12K -2408% Jul 1, 2014 Sep 30, 2014
Q2 2014 -149 Apr 1, 2014 Jun 30, 2014
Q1 2014 -115 Jan 1, 2014 Mar 31, 2014
Q4 2013 -76.5 Oct 1, 2013 Dec 31, 2013
Q3 2013 46.6 Jul 1, 2013 Sep 30, 2013
* An asterisk sign (*) next to the value indicates that the value is likely invalid.